Explore more publications!

Health Observer Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Bermuda.

Press releases published on January 14, 2026

Stead Impact Ventures Leads $15M Series A to Support MedWatch Technologies’ Mission to Advance Metabolic Wellness Innovation
EMJX CEO Eric Jackson to Host Fireside Chat on EMJX Treasury OS Strategy and Governance on January 22nd
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment
24/7 Market News - Kraig Labs Set to Deliver Spider Silk Fiber Samples to Three Industry Partners
Groundwork BioAg Expands in Brazil with Appointment of Roberto Gajardoni as Country Manager
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog
National Survey Exposes Alzheimer’s Care Crisis: High Burden, Low Support, and Uneven Access to Essential Information
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule
Altanine Shares Industry Perspective on the Future of Generics and the Role of Value-Added Formulations
New Randomized Trial Shows Promising Cognitive Gains in Long COVID Brain Fog Using Home-Based Light Therapy
Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
Verano Strengthens National Product Portfolio in Industry’s Fastest-Growing Category with Launch of Swift Lifts as Standalone Pre-roll Brand
Human Appeal Concludes First-Ever U.S. Winter Coat Drive
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions